CTOs on the Move

Access Integrated Healthcare

www.accessih.com

 
Founded by Chief Executive Officer Sam Solakyan, Global Holdings, Inc. has excelled in its journey in becoming leaders in each of the industries it has a presence in. Their main responsibility lies in providing their clients with the most premiere level of service. More than just your typical holdings group, Global is a multifaceted company with financial assets and ownership in the radiology, pharmaceuticals, and medical billing and collections industries. Instead of merely buying and selling companies like other holdings groups, Global searches for the less desirable companies with hidden potential and applies its knowledge and expertise in the management ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.accessih.com
  • 550 N. Brand Blvd. 20th Floor
    Glendale, CA USA 91203
  • Phone: 866.460.7465

Executives

Name Title Contact Details

Similar Companies

Harbor Health Elder Service Plan

Harbor Health Elder Service Plan is a Dorchester Center, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Byte Sized Solutions

Byte Sized Solutions is a Palatine, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nursing Resources

Nursing Resources is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Emocha

Emocha uses video technology and human engagement to empower patients to take every dose of medication as prescribed. emocha facilitates a daily touchpoint for patients in order to expand access to treatment, extend the reach of existing care teams, and retain patients in care. emocha`s turnkey, enterprise adherence solution operates through dose-by-dose observation and clinical assessment of potential administration problems, including technique and side effects. Coupled with daily engagement, support, and incentives, emocha is the first holistic solution to medication non-adherence.

CCBR-SYNARC

Synarc enables its clients to demonstrate the efficacy of new therapies across a broad range of therapeutic areas through highly specialized medical imaging and molecular marker techniques.